Mark L. Bagarazzi

2017

In 2017, Mark L. Bagarazzi earned a total compensation of $1.4M as Chief Medical Officer at Inovio Pharmaceuticals, a 4% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,750
Option Awards$437,586
Salary$435,053
Stock Awards$409,484
Other$13,846
Total$1,444,719

Bagarazzi received $437.6K in option awards, accounting for 30% of the total pay in 2017.

Bagarazzi also received $148.8K in non-equity incentive plan, $435.1K in salary, $409.5K in stock awards and $13.8K in other compensation.

Rankings

In 2017, Mark L. Bagarazzi's compensation ranked 7,188th out of 14,666 executives tracked by ExecPay. In other words, Bagarazzi earned more than 51.0% of executives.

ClassificationRankingPercentile
All
7,188
out of 14,666
51st
Division
Manufacturing
2,671
out of 5,768
54th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
345
out of 856
60th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
175
out of 528
67th
Industry
Surgical and Medical Instruments and Apparatus
107
out of 333
68th
Source: SEC filing on March 28, 2018.

Bagarazzi's colleagues

We found three more compensation records of executives who worked with Mark L. Bagarazzi at Inovio Pharmaceuticals in 2017.

2017

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2017

Niranjan Sardesai

Inovio Pharmaceuticals

Chief Operating Officer

2017

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

News

You may also like